Naofumi Hara

The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Eiki Ichihara, Daijiro Harada, Koji Inoue et al. · Lung Cancer · 2019 · 83 citations

Medicine, Body Mass Index, Immunology +10

The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non–small-cell lung cancer differ based on PD-L1 expression

Nobuaki Ochi, Eiki Ichihara, Nagio Takigawa et al. · European Journal of Cancer · 2021 · 65 citations

Cancer Immunosurveillance, Antibiotics, Pd-l1 Expression +11

Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma

Tomoko Yamagishi, Nobukazu Fujimoto, Hideyuki Nishi et al. · Lung Cancer · 2015 · 60 citations

Lymphocyte-to-monocyte Ratio, Malignant Pleural Mesothelioma, Medicine +8

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 47 citations · Full text

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka et al. · CHEST Journal · 2019 · 36 citations

Cancer Epidemiology, Medicine, Epidemiology Of Cancer +9